Advances in the treatment of tuberculosis

Y. Zhang

Research output: Contribution to journalReview articlepeer-review

Abstract

The current 6-month tuberculosis (TB) therapy is suboptimal with significant side effects and a poor patient compliance problem that frequently selects drug-resistant organisms. The increasing drug-resistant TB problem highlights the need to develop new and more effective drugs. Significant progress has been made recently with several new drug candidates currently in clinical trials. Improved understanding of persister biology and development of persister drugs are likely to be important for developing a more effective therapy.

Original languageEnglish (US)
Pages (from-to)595-600
Number of pages6
JournalClinical pharmacology and therapeutics
Volume82
Issue number5
DOIs
StatePublished - Nov 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Advances in the treatment of tuberculosis'. Together they form a unique fingerprint.

Cite this